Celladon Corporation News Headlines

Get CLDN Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading CLDN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Filtered By
Ordered By

Celladon Lock-Up Expiration Could Be A Short Opportunity For Aggressive Investors
7/16/2014 5:32:00 PM - Seeking Alpha

Healthcare Stocks Turn Positive Late; Celladon Climbs Over 17% After Landing New HQ
6/4/2014 3:59:11 PM - MT Newswires

Sector Update: Healthcare
6/4/2014 3:58:22 PM - MT Newswires

Amid The Biotech Sell-Off, Target This Sector
4/16/2014 8:30:00 AM - Investopedia

3 Stocks To Profit From The Gene Therapy Revolution
4/16/2014 8:30:00 AM - Investopedia

Celladon (CLDN) Jumps: Stock Up 11.5% - Tale of the Tape
4/11/2014 8:51:01 AM -

Celladon (CLDN) Jumps: Stock Up 5.9% - Tale of the Tape
4/1/2014 9:39:01 AM -

Avoid Applied Genetic Technologies IPO
3/26/2014 9:58:00 AM - Seeking Alpha

Biotechs Dominate IPO Calendar, But Most Post Negative Returns
2/6/2014 11:45:00 AM - Seeking Alpha

U.S. IPO Recap: Ultragenyx Doubles And Dicerna Triples In Home-Run Week For Biotech IPOs
2/4/2014 2:25:00 PM - Seeking Alpha

Biotech Boomlet Set To Smash IPO Record For Two-Week Period
2/2/2014 5:42:00 AM - Seeking Alpha

Biotech boomlet set to smash IPO record for two-week period
1/30/2014 6:36:48 PM - Renaissance Capital

Celladon prices upsized IPO at $8
1/29/2014 10:28:21 PM - Renaissance Capital

Celladon revises terms, drops IPO price to $8
1/28/2014 8:56:07 AM - Renaissance Capital

Cardiovascular biotech Celladon revives IPO filing, removes original terms
1/22/2014 9:10:57 AM - Renaissance Capital

Celladon Corporation postpones $75 million IPO
11/14/2013 8:52:45 AM - Renaissance Capital

12 US IPOs planned for the week of Nov 11
11/11/2013 8:00:05 AM - Renaissance Capital

Cardiovascular biotech Celladon sets terms for $75 million IPO
11/1/2013 8:41:30 AM - Renaissance Capital